1. A high-throughput drug screen identifies new therapeutic vulnerabilities in non-small cell lung cancers (NSCLC) with overexpression of the EMT-associated receptor tyrosine kinase AXL. (December 2016) Authors: Cardnell, R.; Tong, P.; Giri, U.; Gudikote, J.; Banerjee, U.; Kalu, N.; Fan, Y.; Nilsson, M.; Johnson, F.; Tran, H.; Wang, J.; Heymach, J.; Byers, L. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase I trial of BI 1810631, a HER2 tyrosine kinase inhibitor (TKI), as monotherapy in patients (pts) with advanced/metastatic solid tumors with HER2 aberrations. (October 2022) Authors: Opdam, F.; Heymach, J.; Barve, M.; Wu, Y.L.; Gibson, N.; Sadrolhefazi, B.; Serra, J.; Yoh, K.; Yamamoto, N. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. G1T28, a CDK4/6 inhibitor, preserves T lymphocyte function from damage by cytotoxic chemotherapy. (December 2016) Authors: Roberts, P.; He, S.; Schvartsman, G.; Patil, T.; Sorrentio, J.; Bisi, J.; Hoyer, R.; Schuster, S.; Strum, J.; Heymach, J.; Ferrarotto, R.; Sharpless, N.; Shapiro, G.; Malik, R. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function. (27th September 2016) Authors: Choi, M.; Kadara, H.; Zhang, J.; Parra, E.R.; Rodriguez-Canales, J.; Gaffney, S.G.; Zhao, Z.; Behrens, C.; Fujimoto, J.; Chow, C.; Kim, K.; Kalhor, N.; Moran, C.; Rimm, D.; Swisher, S.; Gibbons, D.L.; Heymach, J.; Kaftan, E.; Townsend, J.P.; Lynch, T.J. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0143: A Bayesian randomisation trial of IMRT vs. PSPT for locally advanced non-small cell lung carcinoma. (April 2016) Authors: Liao, Z.; Lee, J.; Komaki, R.; Gomez, D.; O'Reilly, M.; Allen, P.; Fossella, F.; Heymach, J.; Choi, N.; Delaney, T.; Hahn, S.; Lu, C.; Cox, J.; Mohan, R. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗